Showing results (501-510 of 516) with videos related to
Sort By:
Pageof 52
Blood Advances|May 27, 2025
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantationIoannis Politikos, Samantha Brown, Joshua A Fein, et al.Gastroenterology|January 27, 2015
Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening populationDouglas K Rex, Samuel N Adler, James Aisenberg, et al.Blood Advances|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myelomaMateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.Haematologica|November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.JAMA Psychiatry|February 3, 2021
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal YouthCheryl A King, David Brent, Jacqueline Grupp-Phelan, et al.JAMA Network Open|February 15, 2023
Prediction of Suicide Attempts and Suicide-Related Events Among Adolescents Seen in Emergency DepartmentsDavid A Brent, Lisa M Horowitz, Jacqueline Grupp-Phelan, et al.Transplantation and Cellular Therapy|August 9, 2022
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell LymphomaKarthik Nath, Ana Alarcon Tomas, Jessica Flynn, et al.British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.Pageof 52